Explore groundbreaking research linking SARS-CoV-2 spike protein accumulation to long-lasting brain effects in long COVID.

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the ...

Researchers have identified that the SARS-CoV-2 spike protein accumulates in the brain's protective layers, potentially ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

What do Kash Patel, Mehmet Oz, and Mike Huckabee have in common? They're all poised to join the Trump administration despite ...

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) ...

"Instead, using our computational bioinformatics tools, we identified two short and simple amino acid sequences in the ...

Robert Redfield says he's "proud" of work on President Trump's initiative but believes COVID vaccines should be "critically ...

Vaccines against both viruses, however, have been difficult to design. Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design ...

A new study reveals that the SARS-CoV-2 spike protein remains in brain-protective tissues and skull bone marrow for years after infection, potentially driving long COVID's neurological symptoms.

Malaria eradication efforts have slowed, highlighting the need for more effective tools. Current malaria vaccines, such as ...

Engineered proteins are critical industrial and medical applications, ranging from vaccine development to making crops or food proteins more resilient. Scientists can engineer proteins to improve upon ...